Impact of the pattern of interstitial lung disease on mortality in rheumatoid arthritis: A systematic literature review and meta-analysis.


Journal

Seminars in arthritis and rheumatism
ISSN: 1532-866X
Titre abrégé: Semin Arthritis Rheum
Pays: United States
ID NLM: 1306053

Informations de publication

Date de publication:
12 2019
Historique:
received: 31 10 2018
revised: 30 01 2019
accepted: 22 04 2019
pubmed: 4 6 2019
medline: 28 7 2020
entrez: 3 6 2019
Statut: ppublish

Résumé

An important extra-articular manifestation of rheumatoid arthritis (RA) is interstitial lung disease (ILD). The relationship between the usual interstitial pneumonia (UIP) pattern and mortality in patients with RA is unclear. The purpose of this study was to complete a systematic literature review and meta-analysis on the association between RA-ILD pattern and mortality risk. We performed a systematic literature review through December 12, 2018. Study characteristics, unadjusted and adjusted relative risks (RR) of mortality for ILD pattern were extracted from the identified studies and quality assessments were performed. RR for mortality (RA-UIP vs. other RA-ILD) was pooled using inverse variance weighting and random effects models. Ten retrospective cohort studies met our eligibility criteria. A total of 1256 RA-ILD patients were included with 484 total deaths. Meta-analysis yielded a pooled RR of 1.66 (95% confidence interval1.07 to 2.56) for death among those with UIP RA-ILD compared with other patterns. In sub-group analysis when pooling studies comparing UIP to NSIP pattern of RA-ILD, the RR was 2.39 (95% CI 0.86-6.68). Through a systematic literature review and meta-analysis, we found UIP pattern to be associated with a higher mortality risk in RA-ILD compared to other patterns of RA-ILD although more recent studies emphasize the importance of pulmonary physiology and the extent of lung involvement as significant predictors of mortality rather than the pattern of RA-ILD. Recognizing the small number of studies satisfying eligibility and inconsistent accounting for confounders, further study of mortality risk in RA-ILD is needed with standardized assessment of various RA, ILD, and patient-related factors.

Identifiants

pubmed: 31153706
pii: S0049-0172(18)30639-5
doi: 10.1016/j.semarthrit.2019.04.005
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

358-365

Informations de copyright

Published by Elsevier Inc.

Auteurs

Namrata Singh (N)

Internal Medicine, University of Iowa Hospitals and Clinics and Iowa City VA, Iowa City, IA, USA. Electronic address: namrata-singh@uiowa.edu.

Jimmy Varghese (J)

Internal Medicine, University of Iowa Hospitals and Clinics and Iowa City VA, Iowa City, IA, USA.

Bryant R England (BR)

VA Nebraska-Western Iowa Health Care System and Division of Rheumatology & Immunology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.

Joshua J Solomon (JJ)

Division of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, CO, USA.

Kaleb Michaud (K)

VA Nebraska-Western Iowa Health Care System and Division of Rheumatology & Immunology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA; FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS, USA.

Ted R Mikuls (TR)

VA Nebraska-Western Iowa Health Care System and Division of Rheumatology & Immunology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.

Heather S Healy (HS)

Hardin Library for the Health Sciences, University of Iowa Libraries, Iowa City, IA, USA.

Emily M Kimpston (EM)

Department of Biostatistics, College of Public Health, Iowa City, IA, USA.

Marin L Schweizer (ML)

Center for Comprehensive Access and Delivery Research & Evaluation, Iowa City VA, Iowa City, IA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH